Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 126 of 5804
-
Magic mushroom compound may turn back the biological clock — a trial investigates
Knowledge-focused Not yet recruitingThe LONG-LIFE study is a randomized Phase I, dose-ranging trial designed to evaluate whether psilocybin impacts aging-related biomarkers, cognitive function, and purpose/meaning in life in medically stable older adults. Up to 50 participants will be enrolled aged 60-80 who will …
Phase: PHASE1 • Sponsor: Charles Raison • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC
-
Immune cell boost may help kids beat Post-Transplant viruses
Disease control Not yet recruitingPatients with refractory ADV or CMV infection post allogeneic stem cell transplant will be randomized to either Family donor-derived viral specific cytotoxic T lymphocytes (CTLs) plus standard of care (SOC) vs SOC alone.
Phase: PHASE3 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Special MRI may help surgeons remove more brain tumor
Disease control Not yet recruitingThis phase III trial compares pH weighted chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI)-based surgical resections to standard of care surgical resections for the treatment of patients with glioblastoma. Standard of care therapy for glioblastoma is …
Phase: PHASE3 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Blood test may let cancer patients take safe breaks from immunotherapy
Disease control Not yet recruitingThis is a multicenter, open-label, randomized (1:1) trial designed to evaluate whether ctDNA-guided interruption of immune-checkpoint inhibitor (ICI) therapy provides comparable survival to standard of care (SoC) continuous ICI therapy in patients with histologically confirmed ad…
Phase: NA • Sponsor: Natera, Inc. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can a gene therapy rewire brain cells to ease Parkinson's?
Disease control Not yet recruitingThis study aims to evaluate the safety, tolerability, and preliminary efficacy of ZR001, a novel chemogenetic gene therapy product, in patients with moderately advanced Parkinson's disease (PD). ZR001 is administered via stereotactic injection into the bilateral substantia nigra,…
Phase: PHASE1 • Sponsor: Qianfoshan Hospital • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New CAR T-Cell combo trial targets tough hodgkin lymphoma in youth
Disease control Not yet recruitingPatients with poor risk classical Hodgkin Lymphoma (cHL) will undergo myeloablative chemotherapy (MAC) with autologous stem cell transplantation (AutoHSCT) and subsequently receive autologous CD30+ CAR T-cells.
Phase: PHASE1, PHASE2 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New drug MHB018A aims to reduce eye bulging in thyroid eye disease
Disease control Not yet recruitingThe primary objective of this study is to evaluate the efficacy of MHB018A injection compared with placebo in participants with chronic moderate-to-severe TED.
Phase: PHASE3 • Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Software-Guided heart valve implant aims to boost precision in aortic stenosis
Disease control Not yet recruitingVOYAGER CE Clinical Study using the Encantor TAVI System.
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Experimental combo therapy targets Hard-to-Treat HER2+ cancers
Disease control Not yet recruitingThis phase Ib study aims to assess the safety and feasibility of combination of chimeric receptor T cells with trastuzumab in patients with HER2+ solid tumors, with further expansion of study population in HER2+ metastatic breast cancer once safety has been established.
Phase: PHASE1, PHASE2 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could Weight-Loss surgery tame a common heart rhythm disorder?
Disease control Not yet recruitingAtrial fibrillation (AF) is the most common sustained cardiac arrhythmia. It is estimated that between 3 and 6 million Americans are currently living with AF, while 12 million people in the United States will have AF in 2030. Obesity and its comorbidities such as type 2 diabetes …
Phase: PHASE4 • Sponsor: Ali Aminian • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New drug cocktail targets deadliest blood cancers
Disease control Not yet recruitingPatients with high-risk myeloid tumors accompanied by TP53 mutations have a poor survival prognosis, and there are still many unmet treatment needs. The current treatment regimens have many limitations. Selinisol, as a novel export protein inhibitor, has good anti-tumor activity.…
Phase: NA • Sponsor: Bing Han • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Targeted drug shows promise for rare vulvar cancer
Disease control Not yet recruitingThis is an open-label, single arm, phase 2 study designed to evaluate the efficacy of tisotumab vedotin in participants with recurrent or metastatic squamous cell carcinoma of the vulva by estimating the objective response rate. Patients will receive tisotumab vedotin every 3 we…
Phase: PHASE2 • Sponsor: GOG Foundation • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Adaptive dosing of immunotherapy shows promise for Tough-to-Treat liver cancer
Disease control Not yet recruitingThe goal of this clinical trial is to learn if immunotherapy including nivolumab plus ipilimumab is effective and safe in treating hepatocellular carcinoma.
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Can a tiny implant trap brain tumor cells and make radiation work better?
Disease control Not yet recruitingThis is a prospective, multicenter, single-arm, pilot clinical investigation, aimed at evaluating the safety and preliminary efficacy of the GlioHook implant in patients with high-grade glioma undergoing surgical resection followed by standard of care (SoC) treatment. GlioHook i…
Phase: NA • Sponsor: Batea Oncology • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Drug cocktail aims to shrink kidney tumors before surgery and prevent return
Disease control Not yet recruitingThis is a multicenter, single-arm, phase 2 clinical trial designed to evaluate the clinical efficacy of combination therapy with zanzalintinib and pembrolizumab in patients with locally advanced intermediate- to high-risk, high-risk, or resectable metastatic clear cell renal cell…
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Precision radiation may better control spine tumors without extra risk
Disease control Not yet recruitingThis study evaluates a new radiation treatment approach for patients with cancer that has spread to the spine (vertebral metastases) and involves limited extension around the spinal cord without causing compression (non-compressive epiduritis). This condition is common and can le…
Phase: NA • Sponsor: Institut Cancerologie de l'Ouest • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New dissolving stent could spare kids repeated heart surgeries
Disease control Not yet recruitingThis study evaluates the safety and effectiveness of the CardiaZn stent, a novel bioresorbable stent designed specifically for infants and children with congenital cardiovascular conditions. Unlike permanent metal stents, the CardiaZn stent is designed to open narrowed blood vess…
Phase: NA • Sponsor: PediaStent LLC • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Freezing away sleep apnea: a new procedure targets throat fat to open the airway
Disease control Not yet recruitingThe objective of this study is to evaluate the safety and effectiveness of the Cryosa System when used as intended to perform the Cryosa Procedure.
Phase: NA • Sponsor: Cryosa, Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New surgery may save more lives from deadly aortic tear
Disease control Not yet recruitingAcute Type A aortic dissection (ATAAD) and its complications are life-threatening conditions that cause more than 1400 hospital admissions and 300 deaths every year in Hong Kong and cause 172,927 deaths globally in 2019. There is an increasing trend in recent years. Given the hy…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Triple-drug attack aims to wipe out hidden leukemia cells
Disease control Not yet recruitingThis is a single-arm, open-label Phase 2 study designed to evaluate the treatment outcomes of nemtabrutinib-venetoclax-obinutuzumab as a frontline management for chronic lymphocytic leukemia (CLL).
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC